Key facts
- Medeta (Clinics/Outpatient Services)’s last known valuation is $4.0M (Dec 2024).
- It has raised $700K; the latest was Seed Round ($700K) in Dec 2024.
- Notable investors include Genesia Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Medeta (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Medeta (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medeta (Clinics/Outpatient Services)
Operator of fertility-focused digital healthcare company intended to expand reproductive medicine expertise through AI and data-driven technologies, making advanced treatments more accessible worldwide. The company offers an integrated digital platform that combines fertility clinic software, embryo evaluation AI and connected management tools, enabling customers to streamline workflows, improve treatment accuracy and deliver reproducible, quality reproductive care.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2022
- Website
- medeta.co.jp/
- Ownership
- Privately Held (backing)
Medeta (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medeta (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medeta (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.